We are live on
!
Find out more
SA
Sicart Associates Portfolio holdings
AUM
$389M
1-Year Est. Return
42.46%
This Fund
S&P 500
This Quarter
Est. Return
+1.92%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$191M
AUM Growth
+$23.3M
(+14%)
Cap. Flow
+$20.6M
Cap. Flow
% of AUM
10.81%
Top 10 Holdings %
Top 10 Hldgs %
51.45%
Holding
95
New
5
Increased
13
Reduced
26
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$7.85M |
| 2 |
Merck
MRK
|
+$4.29M |
| 3 |
Intel
INTC
|
+$4.18M |
| 4 |
Campbell Soup
CPB
|
+$4.18M |
| 5 |
Procter & Gamble
PG
|
+$3.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$727K |
| 2 |
Capital One
COF
|
+$575K |
| 3 |
Boeing
BA
|
+$516K |
| 4 |
Ford
F
|
+$443K |
| 5 |
Nektar Therapeutics
NKTR
|
+$436K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.73% |
| 2 | Energy | 15.98% |
| 3 | Technology | 13.78% |
| 4 | Materials | 8.52% |
| 5 | Consumer Staples | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
iShares Russell 1000 Value ETF
IWD
$82.2B
| $281K | 0.15% |
+2,317
| New | +$282K |
|
77
PTC Therapeutics
PTCT
$5.68B
| $276K | 0.14% |
8,175
| – | – |
|
78
Snap-on
SNA
$21.2B
| $273K | 0.14% |
1,700
| – | – |
|
79
AT&T
T
$159B
| $254K | 0.13% |
10,457
| – | – |
|
80
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $253K | 0.13% |
+5,887
| New | +$262K |
|
81
Targa Resources
TRGP
$58B
| $247K | 0.13% |
5,000
| – | – |
|
|
SCS
82
DELISTED
Steelcase
SCS
| $239K | 0.13% |
17,500
| – | – |
|
83
Home Depot
HD
$331B
| $234K | 0.12% |
1,200
| – | – |
|
84
Autodesk
ADSK
$49.5B
| $223K | 0.12% |
1,700
| – | – |
|
85
Walmart Inc
WMT
$885B
| $223K | 0.12% |
7,800
| – | – |
|
86
Howmet Aerospace
HWM
$113B
| $210K | 0.11% |
16,125
| – | – |
|
|
XYZ
87
Block Inc
XYZ
$48.4B
| $200K | 0.1% |
3,240
-2,760
| -46% | -$152K |
|
88
Mitsubishi UFJ Financial
MUFG
$253B
| $86K | 0.05% |
15,000
| – | – |
|
|
89
Capital One
COF
$128B
| – | – |
-6,000
| Closed | -$575K |
|
|
90
Ford
F
$58.5B
| – | – |
-40,000
| Closed | -$443K |
|
|
91
Nektar Therapeutics
NKTR
$2.39B
| – | – |
-273
| Closed | -$436K |
|
92
Rockwell Automation
ROK
$53.4B
| – | – |
-1,200
| Closed | -$209K |
|
93
Synchrony
SYF
$24.7B
| – | – |
-7,500
| Closed | -$251K |
|
94
Target
TGT
$65.6B
| – | – |
-5,000
| Closed | -$347K |
|
Similar funds
AIM
WCM
HP
P8IP
PFPGI
PG
S
LHC
Sicart Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Sicart Associates held 95 positions worth $191M, up 14% from $167M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Sicart Associates deployed $20.6M of net new capital in Q2 2018, opening 5 new positions and adding to 13 existing holdings. Its largest new stake was Invesco China Small Cap ETF: 36,660 shares worth $1.08M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 16% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Microsoft, an estimated $727K trimmed.
- Sicart Associates's largest Q2 2018 buy was Invesco China Small Cap ETF: 36,660 shares worth $1.08M.
- Sicart Associates added most to Ionis Pharmaceuticals in Q2 2018, an estimated $7.85M increase.
- Sicart Associates's biggest Q2 2018 reduction was Microsoft, cutting an estimated $727K.
- Sicart Associates fully exited Capital One in Q2 2018, selling an estimated $575K.
- Sicart Associates's ten largest holdings make up 51% of its $191M portfolio in Q2 2018.
- Sicart Associates opened 5 new positions and closed 7 in Q2 2018.
- Sicart Associates's portfolio value rose 14% quarter-over-quarter to $191M.
Based on Sicart Associates's 13F filing for Q2 2018, filed 19 Jul 2018.